Lido Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Sell |
208,432
-3,434
| -2% | -$237K | 0.06% | 188 |
|
|
2025
Q1 | $14.9M | Buy |
211,866
+38,463
| +22% | +$2.71M | 0.07% | 167 |
|
|
2024
Q4 | $14.9M | Buy |
173,403
+654
| +0.4% | +$56.3K | 0.07% | 158 |
|
|
2024
Q3 | $20.6M | Buy |
172,749
+21,087
| +14% | +$2.51M | 0.1% | 92 |
|
|
2024
Q2 | $21.6M | Buy |
151,662
+5,236
| +4% | +$747K | 0.12% | 86 |
|
|
2024
Q1 | $18.9M | Buy |
146,426
+11,076
| +8% | +$1.43M | 0.11% | 87 |
|
|
2023
Q4 | $14M | Buy |
135,350
+10,490
| +8% | +$1.09M | 0.09% | 110 |
|
|
2023
Q3 | $11.4M | Buy |
124,860
+5,814
| +5% | +$529K | 0.09% | 118 |
|
|
2023
Q2 | $9.63M | Buy |
119,046
+105,068
| +752% | +$8.5M | 0.07% | 141 |
|
|
2023
Q1 | $1.11M | Buy |
13,978
+4,582
| +49% | +$365K | 0.01% | 418 |
|
|
2022
Q4 | $636K | Buy |
9,396
+1,626
| +21% | +$110K | 0.01% | 464 |
|
|
2022
Q3 | $387K | Buy |
7,770
+606
| +8% | +$30.2K | ﹤0.01% | 559 |
|
|
2022
Q2 | $399K | Buy |
7,164
+1,374
| +24% | +$76.5K | 0.01% | 535 |
|
|
2022
Q1 | $321K | Buy |
5,790
+1,034
| +22% | +$57.3K | ﹤0.01% | 703 |
|
|
2021
Q4 | $266K | Buy |
+4,756
| New | +$266K | ﹤0.01% | 750 |
|